January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA
Aug 27, 2024, 21:52

David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA

David Gandara, Co-Director-Center for Experimental Therapeutics at UC Davis Comprehensive Cancer Center, shared a post on X:

“At Cal Cancer Consortium conference, Jonathan Riess shows impact of baseline positive vs negative plasma ctDNA for EGFR in the FLAURA2 trial. Addition of chemo to Osi mainly benefitting those with positive ctDNA. Food for thought!”

David Gandara: Jonathan Riess about impact of baseline positive vs negative plasma ctDNA

Source: David Gandara/X